세계의 면역독소 시장 보고서(2025년)

Immunotoxin Global Market Report 2025

US $ 4,490 ￦ 6,437,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,304,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,172,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

면역독소 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 939억 3,000만 달러로 CAGR 9.0%로 성장할 것으로 예상됩니다. 예측 기간 동안의 성장은 암 발병률 증가, 천연 및 유기농 제품에 대한 수요 증가, 화장품 산업 확대, R&D 자금 확대, 헬스케어 인프라 개선 등에 기인하는 것으로 분석됩니다. 예측 기간 동안 주요 동향으로는 정밀의료 접근법, 타겟팅 전략 강화, 다기능 면역독소, 병용요법, 단클론항체 기술의 발전 등을 꼽을 수 있습니다.

유방암 발병률의 증가는 면역독소 시장의 성장을 견인할 것으로 예상됩니다. 유방암은 유방 세포에서 발생하는 암의 일종이지만, 검진 개선, 생활습관 변화, 평균 수명 증가 등의 요인으로 인해 유방암이 더 흔해지고 있습니다. 면역독소는 건강한 세포를 보존하면서 암세포를 특이적으로 표적화하여 사멸시킴으로써 기존 화학요법에서 흔히 나타나는 부작용을 줄여 유방암 치료를 돕습니다. 예를 들어, 미국 비영리단체인 미국암협회에 따르면, 2023년 보고된 유방암 신규 환자 수는 300,590명으로 2022년 290,560명보다 증가할 것으로 예상하고 있습니다. 이처럼 유방암 발병률의 증가는 면역독소 시장 확대에 박차를 가하고 있습니다.

암 치료의 정확성과 효능을 향상시키기 위해 항체약물접합체(ADC)의 개발에 주력하고 있는 면역독극물 시장의 주요 기업들은 표적 암 치료를 위해 설계된 바이오의약품으로, 세포독성 약물에 결합된 항체로 구성되어 특정 항원을 발현하는 암세포에 약물을 표적 전달할 수 있습니다. 예를 들어, 2024년 4월 미국 제약회사 화이자와 덴마크의 생명공학 기업 Genmab A/S는 전이성 또는 재발성 자궁경부암 환자를 치료하기 위해 설계된 항체약물접합체 TIVDAK에 대한 미국 식품의약국(FDA)의 완전한 승인을 획득했습니다. TIVDAK의 독성 페이로드인 모노메틸아우리스타틴 E는 세포 사멸을 유도하는 미세관 파괴제입니다. 이 새로운 기전은 TIVDAK의 암 치료 효과에 기여하고 있으며, 전체 생존기간에서 통계적으로 유의미한 개선을 보여 재발 및 전이성 자궁경부암 환자들에게 유망한 선택이 될 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신종 코로나바이러스 감염증, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 면역독소 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 면역독소 시장 : 성장률 분석
• 세계의 면역독소 시장 실적 : 규모와 성장, 2019-2024
• 세계의 면역독소 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 면역독소 전체 시장(TAM)

제6장 시장 세분화

• 세계의 면역독소 시장 : 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 탄저균 유래 독소
• 디프테리아 독소(DT) 및 유도체
• 슈도모나스 외독소(PE) 및 유도체
• 리보솜 불활성화 단백질 기반 면역독소
• 리보누크레아제 기반 면역독소
• 기타 유형
• 세계의 면역독소 시장 : 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 고형 종양
• 백혈병
• 기타 용도
• 세계의 면역독소 시장 : 최종사용자별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 병원과 진료소
• 암·방사선 치료 센터
• 조사실
• 기타 최종사용자
• 세계의 면역독소 시장, 탄저균 유래 독소 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 탄저균 치사 독소
• 탄저균 방어 항원
• 세계의 면역독소 시장, 디프테리아 독소(DT) 및 유도체 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 디프테리아 독소
• DT 프래그먼트 기반 면역독소
• 세계의 면역독소 시장, 슈도모나스 외독소(PE) 및 유도체 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• PE38 기반 면역독소
• PE 기반 융합 단백질
• 세계의 면역독소 시장, 리보솜 불활성화 단백질 기반 면역독소 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 리신베이스 면역독소
• 게로닌베이스 면역독소
• 세계의 면역독소 시장, 리보누크레아제 기반 면역독소 종류별 하위 세분화, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 온코나제 기반 면역독소
• 비나제 기반 면역독소
• 세계의 면역독소 시장, 기타 유형 하위 세분화, 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 시가 독소 기반 면역독소
• 기타 독소 기반 면역독소

제7장 지역별·국가별 분석

• 세계의 면역독소 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 면역독소 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 면역독소 시장 : 경쟁 구도
• 면역독소 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Bristol Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업과 혁신적 기업

• Thermo Fisher Scientific Inc.
• AstraZeneca plc
• Merck KGaA
• BioNTech SE
• Ipsen Pharma
• Seagen Inc.
• Orion Corporation
• GenScript
• Cytek Biosciences
• MacroGenics Inc.
• Sutro Biopharma Inc.
• Sorrento Therapeutics Inc.
• Innate Pharma Inc.
• Cayman Chemical
• ImmunoGen Inc.

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 면역독소 시장 2029 : 새로운 기회를 제공하는 국가
• 면역독소 시장 2029 : 새로운 기회를 제공하는 부문
• 면역독소 시장 2029 : 성장 전략
  • 시장 동향에 기반한 전략
  • 경쟁 전략

제36장 부록

ksm

영문 목차

영문목차

Immunotoxins are bioengineered proteins that combine an antibody or antibody fragment with a toxin to specifically target and destroy certain cells, such as cancer cells. The antibody segment of the immunotoxin attaches to a specific antigen on the surface of the target cell, delivering the toxin directly to it. Immunotoxins are crafted to avoid harming healthy cells and tissues, thereby reducing side effects compared to traditional chemotherapy.

The primary types of immunotoxins include anthrax-based toxins, diphtheria toxin (DT) and its derivatives, pseudomonas exotoxin (PE) and its derivatives, ribosome-inactivating protein-based immunotoxins, ribonuclease-based immunotoxins, among others. Anthrax-based toxins are substances produced by the bacteria that cause anthrax, a severe disease. These toxins are used in various applications, including the treatment of solid tumors, leukemias, and more, by different end users such as hospitals and clinics, cancer and radiation therapy centers, research laboratories, and others.

The immunotoxins market research report is one of a series of new reports from The Business Research Company that provides immunotoxins market statistics, including the immunotoxins industry global market size, regional shares, competitors with immunotoxins market share, detailed immunotoxins market segments, market trends, and opportunities, and any further data you may need to thrive in the immunotoxins industry. These immunotoxins market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The immunotoxin market size has grown strongly in recent years. It will grow from $60.97 billion in 2024 to $66.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to the discovery of target antigens, advancements in monoclonal antibody technology, preclinical efficacy studies, clinical trials and regulatory approval, and identification of resistance mechanisms.

The immunotoxin market size is expected to see strong growth in the next few years. It will grow to $93.93 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the increasing incidence of cancer, rising demand for natural and organic products, expansion of the cosmetic industry, expansion of R and D financing, and improving healthcare infrastructure. Major trends in the forecast period include precision medicine approach, enhanced targeting strategies, multifunctional immunotoxins, combination therapies, and advancements in monoclonal antibody technology.

The rising incidence of breast cancer is anticipated to drive the growth of the immunotoxin market. Breast cancer, a type of cancer that develops in breast cells, is becoming more common due to factors such as improved screening, lifestyle changes, and increased life expectancy. Immunotoxins assist in breast cancer treatment by specifically targeting and killing cancer cells while sparing healthy cells, thereby reducing the side effects commonly associated with traditional chemotherapy. For example, according to the American Cancer Society, a US-based non-profit organization, there were 300,590 new cases of breast cancer reported in 2023, an increase from the 290,560 cases reported in 2022. Thus, the rising incidence of breast cancer is fueling the expansion of the immunotoxin market.

Leading companies in the immunotoxin market are concentrating on developing antibody-drug conjugates (ADCs) to improve the precision and effectiveness of cancer treatments. ADCs are biopharmaceuticals designed for targeted cancer therapy, consisting of an antibody linked to a cytotoxic drug, which allows for the targeted delivery of the drug to cancer cells expressing a specific antigen. For instance, in April 2024, Pfizer Inc., a US-based pharmaceutical company, and Genmab A/S, a Denmark-based biotechnology company, received full U.S. Food and Drug Administration (FDA) approval for TIVDAK, an antibody-drug conjugate designed to treat patients with metastatic or recurrent cervical cancer. TIVDAK's toxic payload, monomethyl auristatin E, is a microtubule-disrupting agent that induces cell death. This novel mechanism contributes to its effectiveness in cancer treatment. TIVDAK demonstrated statistically significant improvements in overall survival, making it a promising option for patients with recurrent or metastatic cervical cancer.

In February 2024, AbbVie, a US-based biopharmaceutical company, acquired ImmunoGen, Inc. for an undisclosed amount. Through this acquisition, AbbVie seeks to strengthen its oncology portfolio by incorporating ImmunoGen's cutting-edge antibody-drug conjugate technology, thus advancing the development of targeted cancer therapies. ImmunoGen, Inc. is a biotechnology company specializing in immunotoxins.

Major companies operating in the immunotoxin market are Pfizer Inc., Roche Holding AG, AbbVie Inc., Bayer AG, Bristol Myers Squibb, Thermo Fisher Scientific Inc., AstraZeneca plc, Merck KGaA, BioNTech SE, Ipsen Pharma, Seagen Inc., Orion Corporation, GenScript, Cytek Biosciences, MacroGenics Inc., Sutro Biopharma Inc., Sorrento Therapeutics Inc., Innate Pharma Inc., Cayman Chemical, ImmunoGen Inc., Mersana Therapeutics, Molecular Templates Inc., Celldex Therapeutics, CytImmune Sciences Inc., Enzo Life Sciences Inc.

North America was the largest region in the immunotoxin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunotoxin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the immunotoxin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The immunotoxin market consists of sales of linker molecules, expression systems, antibody or antibody fragments, and cytotoxic agents. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunotoxin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunotoxin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunotoxin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunotoxin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Anthrax Based Toxins; Diphtheria Toxin (DT) And Derivatives; Pseudomonas Exotoxin (PE) And Derivatives; Ribosome Inactivating Proteins Based Immunotoxins; Ribonucleases-Based Immunotoxins; Other Types
• 2) By Application: Solid Tumors; Leukemias; Other Applications
• 3) By End User: Hospitals And Clinics; Cancer And Radiation Therapy Centers; Research Labs; Other End-Users
• Subsegments:
• 1) By Anthrax-Based Toxins: Anthrax Lethal Toxin; Anthrax Protective Antigen
• 2) By Diphtheria Toxin (DT) And Derivatives: Diphtheria Toxin; DT Fragment-Based Immunotoxins
• 3) By Pseudomonas Exotoxin (PE) And Derivatives: PE38-Based Immunotoxins; PE-Based Fusion Proteins
• 4) By Ribosome Inactivating Proteins-Based Immunotoxins: Ricin-Based Immunotoxins; Gelonin-Based Immunotoxins
• 5) By Ribonucleases-Based Immunotoxins: Onconase-Based Immunotoxins; Binase-Based Immunotoxins
• 6) By Other Types: Shiga Toxin-Based Immunotoxins; Other Toxin-Based Immunotoxins
• Companies Mentioned: Pfizer Inc.; Roche Holding AG; AbbVie Inc.; Bayer AG; Bristol Myers Squibb
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunotoxin Market Characteristics

3. Immunotoxin Market Trends And Strategies

4. Immunotoxin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Immunotoxin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Immunotoxin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Immunotoxin Market Growth Rate Analysis
• 5.4. Global Immunotoxin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Immunotoxin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Immunotoxin Total Addressable Market (TAM)

6. Immunotoxin Market Segmentation

• 6.1. Global Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anthrax Based Toxins
• Diphtheria Toxin (DT) And Derivatives
• Pseudomonas Exotoxin (PE) And Derivatives
• Ribosome Inactivating Proteins Based Immunotoxins
• Ribonucleases-Based Immunotoxins
• Other Types
• 6.2. Global Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Solid Tumors
• Leukemias
• Other Applications
• 6.3. Global Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Cancer And Radiation Therapy Centers
• Research Labs
• Other End-Users
• 6.4. Global Immunotoxin Market, Sub-Segmentation Of Anthrax-Based Toxins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Anthrax Lethal Toxin
• Anthrax Protective Antigen
• 6.5. Global Immunotoxin Market, Sub-Segmentation Of Diphtheria Toxin (DT) And Derivatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Diphtheria Toxin
• DT Fragment-Based Immunotoxins
• 6.6. Global Immunotoxin Market, Sub-Segmentation Of Pseudomonas Exotoxin (PE) And Derivatives, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PE38-Based Immunotoxins
• PE-Based Fusion Proteins
• 6.7. Global Immunotoxin Market, Sub-Segmentation Of Ribosome Inactivating Proteins-Based Immunotoxins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ricin-Based Immunotoxins
• Gelonin-Based Immunotoxins
• 6.8. Global Immunotoxin Market, Sub-Segmentation Of Ribonucleases-Based Immunotoxins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Onconase-Based Immunotoxins
• Binase-Based Immunotoxins
• 6.9. Global Immunotoxin Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Shiga Toxin-Based Immunotoxins
• Other Toxin-Based Immunotoxins

7. Immunotoxin Market Regional And Country Analysis

• 7.1. Global Immunotoxin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Immunotoxin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunotoxin Market

• 8.1. Asia-Pacific Immunotoxin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunotoxin Market

• 9.1. China Immunotoxin Market Overview
• 9.2. China Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunotoxin Market

• 10.1. India Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunotoxin Market

• 11.1. Japan Immunotoxin Market Overview
• 11.2. Japan Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunotoxin Market

• 12.1. Australia Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunotoxin Market

• 13.1. Indonesia Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunotoxin Market

• 14.1. South Korea Immunotoxin Market Overview
• 14.2. South Korea Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunotoxin Market

• 15.1. Western Europe Immunotoxin Market Overview
• 15.2. Western Europe Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunotoxin Market

• 16.1. UK Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunotoxin Market

• 17.1. Germany Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunotoxin Market

• 18.1. France Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunotoxin Market

• 19.1. Italy Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunotoxin Market

• 20.1. Spain Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunotoxin Market

• 21.1. Eastern Europe Immunotoxin Market Overview
• 21.2. Eastern Europe Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunotoxin Market

• 22.1. Russia Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunotoxin Market

• 23.1. North America Immunotoxin Market Overview
• 23.2. North America Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunotoxin Market

• 24.1. USA Immunotoxin Market Overview
• 24.2. USA Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunotoxin Market

• 25.1. Canada Immunotoxin Market Overview
• 25.2. Canada Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunotoxin Market

• 26.1. South America Immunotoxin Market Overview
• 26.2. South America Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunotoxin Market

• 27.1. Brazil Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunotoxin Market

• 28.1. Middle East Immunotoxin Market Overview
• 28.2. Middle East Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunotoxin Market

• 29.1. Africa Immunotoxin Market Overview
• 29.2. Africa Immunotoxin Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Immunotoxin Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Immunotoxin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunotoxin Market Competitive Landscape And Company Profiles

• 30.1. Immunotoxin Market Competitive Landscape
• 30.2. Immunotoxin Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Bristol Myers Squibb Overview, Products and Services, Strategy and Financial Analysis

31. Immunotoxin Market Other Major And Innovative Companies

• 31.1. Thermo Fisher Scientific Inc.
• 31.2. AstraZeneca plc
• 31.3. Merck KGaA
• 31.4. BioNTech SE
• 31.5. Ipsen Pharma
• 31.6. Seagen Inc.
• 31.7. Orion Corporation
• 31.8. GenScript
• 31.9. Cytek Biosciences
• 31.10. MacroGenics Inc.
• 31.11. Sutro Biopharma Inc.
• 31.12. Sorrento Therapeutics Inc.
• 31.13. Innate Pharma Inc.
• 31.14. Cayman Chemical
• 31.15. ImmunoGen Inc.

32. Global Immunotoxin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunotoxin Market

34. Recent Developments In The Immunotoxin Market

35. Immunotoxin Market High Potential Countries, Segments and Strategies

• 35.1 Immunotoxin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Immunotoxin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Immunotoxin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료